Research never stops

Archive



Dec 09, 2016

Evotec and Forge Therapeutics form strategic 'superbug' alliance

Hamburg, Germany, 09 December 2016: Evotec AG today announced a strategic alliance with Forge Therapeutics, Inc. to advance its novel Gram-negative antibiotic programme targeting 'LpxC' for the treatment of bacterial infections including those caused by drug resistant 'superbugs'.

- read more
Nov 30, 2016

Evotec and Merck enter into agreements to collaborate on target discovery technologies

Hamburg, Germany, 30 November 2016: Evotec AG today announced the signing of a set of collaboration agreements with the life science business of Merck, which will combine Merck's portfolio of genome editing technologies with Evotec's versatile screening platforms and disease expertise.

- read more
Nov 10, 2016

Evotec AG reports results of first nine months of 2016

Hamburg, Germany, 10 November 2016: Evotec AG today reported financial results and corporate updates for the first nine months of 2016.

- read more
Nov 10, 2016

Evotec and Oxford create novel Partnership called 'LAB282'

Oct 26, 2016

Evotec announces its intent to acquire Cyprotex PLC

Oct 20, 2016

Evotec and UCB sign multi-year CNS pharmacology agreement

Oct 04, 2016

Evotec and Carrick Therapeutics build strategic alliance

Sep 29, 2016

Evotec receives further important pre-clinical milestone in endometriosis alliance with Bayer

Sep 28, 2016

Evotec enters into strategic multi-target alliance with C4X Discovery

Sep 22, 2016

Evotec enters into a research collaboration with Inserm in oncology

Sep 21, 2016

Evotec and Bayer partner to develop new treatments to fight kidney diseases

Aug 10, 2016

Evotec AG reports results of first half of 2016

Aug 04, 2016

Evotec achieves clinical development milestone as part of its multi-target alliance with Bayer in endometriosis

Jul 19, 2016

Evotec AG increases its profitability guidance for 2016

Jul 11, 2016

Evotec awarded contract from Antibiotic Research UK to begin integrated drug discovery collaboration

Jul 06, 2016

Evotec enters license agreement for access to CRISPR-Cas9 gene editing technology

Jun 29, 2016

Evotec and Ellersbrook join forces to accelerate TargetNASH

Jun 14, 2016

Resolutions of the Annual General Meeting of Evotec AG

Jun 10, 2016

Evotec receives European Mediscience Award for ‘Best Communication’

May 24, 2016

Evotec extends integrated drug discovery alliance with Genentech

May 10, 2016

Evotec AG reports results of first quarter 2016

Apr 26, 2016

Evotec and ex scientia announce partnership to discover bispecific small molecule immuno-oncology therapeutics

Apr 19, 2016

Evotec and Pierre Fabre sign multi-year compound management agreement

Mar 22, 2016

Evotec FY 2015: Excellent execution meets first-in-class innovation

Mar 22, 2016

Evotec spins off auto-immune disease company as 'Topas Therapeutics GmbH'

Mar 10, 2016

Evotec achieves milestone in collaboration with Padlock Therapeutics

Feb 02, 2016

Evotec awarded grant from The Michael J. Fox Foundation for Parkinson's Research

Jan 12, 2016

Evotec achieves important milestone in TargetAD collaboration with Janssen in Alzheimer's disease

Jan 07, 2016

Evotec and UCB sign multi-year sample management agreement

Watch a short video clip on this press release

- read more